Key result
Redo-TAVR (TAV-in-TAV) is a promising strategy for managing bioprosthetic valve failure, requiring careful preprocedural planning and multidisciplinary assessment to minimize complications.
Why the study?
As TAVR expands to younger patients, the likelihood of bioprosthetic valve failure increases, highlighting the need for effective long-term management strategies such as redo-TAVR.
Design
Review
Authors
Loading...
May support redo-TAVR evaluation in select BVF; leaves open need for prospective durability data in younger patients.
This review highlights the technical considerations, challenges, and importance of preprocedural planning for redo-TAVR (TAV-in-TAV) in managing bioprosthetic valve failure.
Fabris et al. (2026) conducted a review in Bioprosthetic valve failure after TAVR. Redo-TAVR (TAV-in-TAV) was evaluated. Redo-TAVR (TAV-in-TAV) is a promising strategy for managing bioprosthetic valve failure, requiring careful preprocedural planning and multidisciplinary assessment to minimize complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: